Announcements Trials

Browse Landscape

Phase

Phase 3 2 Phase NA 1 Phase 4 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 1

Interventions

Oxaliplatin 21 Capecitabine 19 Fluorouracil 16 Bevacizumab 16 Esomeprazole 11 Sorafenib 10 Irinotecan 9 Leucovorin 8 Radiofrequency Ablation 7 Propofol 7 Bismuth 7 Morphine 6 Gemcitabine 6 Folfox protocol 6 Amoxicillin 6 lenvatinib 5 gadolinium ethoxybenzyl DTPA 5 Tetracycline 5 Sevoflurane 5 S 1 (combination) 5 Drug Therapy 5 Control Groups 5 Cisplatin 5 sodium glycididazole 4 fish oil triglycerides 4 ferric carboxymaltose 4 Sodium Chloride 4 Ropivacaine 4 Ribavirin 4 Hepatectomy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × contrast agent BR1 × Gastrointestinal × Clear all

NCT04569799 2023-11-02

TACE

Milton S. Hershey Medical Center

Phase 4 Completed

26 enrolled 10 charts

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡